Biomark DiagnosticsBUX 
$0.180.00%24h
0.00%24h
Global rank31061
Market cap$14.64M
Change 7d0.00%
YTD Performance-4.00%
SP500 benchmarkUnderperform
P/E-8.85
P/S129.43
Revenue$113.14K
Earnings-$1.36M
Dividend yield-
Main Sector
Healthcare
EPS for Biomark Diagnostics (BUX)
Biomark Diagnostics has an EPS of $-0.02. In 2022, the company made an earnings per share (EPS) of $-0.02. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for BUX
-
Value:-
EPS history for Biomark Diagnostics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.02 | 0.00% |
| 2022 | -$0.02 | 0.00% |
| 2021 | -$0.02 | 0.00% |
| 2020 | -$0.02 | - |
View the highest EPS stocks
